Giovanni Borasi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Giovanni Borasi has a total of 163 co-authors. Here are the top co-authors by number of shared publications:
- Marco Bertolini
Medical Physics Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy
12 shared publications - Maria Carla Gilardi
Istituto di Bioimmagini e Fisiologia Molecolare - Consiglio Nazionale delle Ricerche (IBFM-CNR)
7 shared publications - Giorgio Russo
Institute of Bioimaging and Complex Biological Systems-National Research Council (IBSBC-CNR), 90015 Cefalù, Italy
6 shared publications Federica Fioroni
5 shared publicationsNico Lanconelli
5 shared publicationsStefano Rivetti
Department of Physics, Alma Mater Studiorum, University of Bologna, Bologna 40127, Italy
5 shared publications
Latest Publications
- 1 December 2015
- Published by Elsevier in Physica Medica
- Vol. 31 (8) , 1060-1064
A new definition of biological effective dose: The dose distribution effects
- 1 December 2015
- Published by Elsevier in Physica Medica
- Vol. 31 (8) , 1060-1064
A new definition of biological effective dose: The dose distribution effects
- 1 July 2014
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 89 (4) , 926-927
Cancer Therapy Combining High-Intensity Focused Ultrasound and Megavoltage Radiation
- 1 July 2014
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 89 (4) , 926-927
Cancer Therapy Combining High-Intensity Focused Ultrasound and Megavoltage Radiation
- Open Access
- 31 March 2014
- Published by Wiley in Concurrency and Computation: Practice and Experience
- Vol. 27 (2) , 458-472
A GEANT4 web‐based application to support Intra‐Operative Electron Radiotherapy using the European grid infrastructure
- 31 March 2014
- Published by Wiley in Concurrency and Computation: Practice and Experience
- Vol. 27 (2) , 458-472
Open AccessA GEANT4 web‐based application to support Intra‐Operative Electron Radiotherapy using the European grid infrastructure
- 1 January 2014
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 111, S272
EP-1759: Integration of DICOM images in a Geant4 application : A support forintra-operative radiotherapy clinical research
- 1 January 2014
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 111, S272
EP-1759: Integration of DICOM images in a Geant4 application : A support forintra-operative radiotherapy clinical research
- 1 January 2014
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 111, S181-S182
EP-1545: A fast Monte Carlo-based calculation algorithm for a Intra-Operative Radiation Therapy TPS : A validation study
- 1 January 2014
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 111, S181-S182
EP-1545: A fast Monte Carlo-based calculation algorithm for a Intra-Operative Radiation Therapy TPS : A validation study
- Open Access
- 1 January 2013
- Published by Springer Nature in Journal of Therapeutic Ultrasound
- Vol. 1 (1) , 6
High-intensity focused ultrasound plus concomitant radiotherapy: a new weapon in oncology?
The potential impact of high-intensity focused ultrasound (HIFU) to general medicine and oncology seems very high. However, while in the research area, the development of this technique is very rapid and unchallenged. The direct application of HIFU to human tumour therapy is hampered by various technical difficulties, which may confine its role to a marginal device in the surgery armamentarium. To deploy the full potential of focused ultrasound in oncology, it seems necessary to review the basic relationship between HIFU and external beam radiotherapy. This is the aim of the present work.
- 1 January 2013
- Published by Springer Nature in Journal of Therapeutic Ultrasound
- Vol. 1 (1) , 6
Open AccessHigh-intensity focused ultrasound plus concomitant radiotherapy: a new weapon in oncology?
The potential impact of high-intensity focused ultrasound (HIFU) to general medicine and oncology seems very high. However, while in the research area, the development of this technique is very rapid and unchallenged. The direct application of HIFU to human tumour therapy is hampered by various technical difficulties, which may confine its role to a marginal device in the surgery armamentarium. To deploy the full potential of focused ultrasound in oncology, it seems necessary to review the basic relationship between HIFU and external beam radiotherapy. This is the aim of the present work.
- Open Access
- 6 September 2012
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 13 (5) , 74-92
Dose distribution changes with shielding disc misalignments and wrong orientations in breast IOERT: a Monte Carlo – GEANT4 and experimental study
One of the most relevant risks in breast intraoperative electron radiotherapy (IOERT) is the incorrect positioning of the shielding disc. If such a setup error occurs, the treatment zone could receive a nonuniform dose delivery, and a considerable part of the electron beam could hit — and irradiate — the patient's healthy tissue. However misalignment and tilt angle of the shielding disc can be evaluated, but it is not possible to measure the corresponding in vivo dose distribution. This led us to develop a simulation using the Geant4 Monte Carlo toolkit to study the effects of disc configuration on dose distribution. Some parameters were investigated: the shielding factor (SF), the radiation back scattering factor (BSF), the volume–dose histogram in the treatment zone, and the maximum leakage dose (MLD) in normal tissue. A lateral shift of the disc (in the plane perpendicular to the beam axis) causes a decrease in SF (from 4% for a misalignment of 5 mm to 40% for a misalignment of 40 mm), but no relevant dose variations were found for a tilt angle until 10°. In the same uncorrected disc positions, the BSF shows no significant change. MLD rises to 3.45 Gy for a 14 mm misalignment and 4.60 Gy for 30° tilt angle when the prescribed dose is 21 Gy. The simulation results are compared with the experimental ones, and allow an a posteriori estimation of the dose distribution in the breast target and underlying healthy tissue. This information could help the surgical team choose a more correct clinical setup, and assist in quantifying the degree of success or failure of an IOERT breast treatment.PACS number: 87.53.Jw, 87.55.dk, 87.55.Gh, 87.55.K‐, 87.55.N‐
- 6 September 2012
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 13 (5) , 74-92
Open AccessDose distribution changes with shielding disc misalignments and wrong orientations in breast IOERT: a Monte Carlo – GEANT4 and experimental study
One of the most relevant risks in breast intraoperative electron radiotherapy (IOERT) is the incorrect positioning of the shielding disc. If such a setup error occurs, the treatment zone could receive a nonuniform dose delivery, and a considerable part of the electron beam could hit — and irradiate — the patient's healthy tissue. However misalignment and tilt angle of the shielding disc can be evaluated, but it is not possible to measure the corresponding in vivo dose distribution. This led us to develop a simulation using the Geant4 Monte Carlo toolkit to study the effects of disc configuration on dose distribution. Some parameters were investigated: the shielding factor (SF), the radiation back scattering factor (BSF), the volume–dose histogram in the treatment zone, and the maximum leakage dose (MLD) in normal tissue. A lateral shift of the disc (in the plane perpendicular to the beam axis) causes a decrease in SF (from 4% for a misalignment of 5 mm to 40% for a misalignment of 40 mm), but no relevant dose variations were found for a tilt angle until 10°. In the same uncorrected disc positions, the BSF shows no significant change. MLD rises to 3.45 Gy for a 14 mm misalignment and 4.60 Gy for 30° tilt angle when the prescribed dose is 21 Gy. The simulation results are compared with the experimental ones, and allow an a posteriori estimation of the dose distribution in the breast target and underlying healthy tissue. This information could help the surgical team choose a more correct clinical setup, and assist in quantifying the degree of success or failure of an IOERT breast treatment.PACS number: 87.53.Jw, 87.55.dk, 87.55.Gh, 87.55.K‐, 87.55.N‐
- 1 January 2012
- Published by AIP Publishing in AIP Conference Proceedings
- Vol. 1503 (1) , 168-172
Metabolic changes after MRgFUS treatment of a bone metastasis using PET/CT: A case report
Aim of the present study is to evaluate the efficacy of the Magnetic Resonance guided Focused Ultrasound (Insightec ExAblate 2000 system) in a clinical case of a pelvic bone metastasis, accessible to the ultrasonic beam. Multiple 18F-FDG PET/CT examinations allowed to follow the metabolic and morphological modification of the cancerous lesion.
- 1 January 2012
- Published by AIP Publishing in AIP Conference Proceedings
- Vol. 1503 (1) , 168-172
Metabolic changes after MRgFUS treatment of a bone metastasis using PET/CT: A case report
Aim of the present study is to evaluate the efficacy of the Magnetic Resonance guided Focused Ultrasound (Insightec ExAblate 2000 system) in a clinical case of a pelvic bone metastasis, accessible to the ultrasonic beam. Multiple 18F-FDG PET/CT examinations allowed to follow the metabolic and morphological modification of the cancerous lesion.
- 27 July 2011
- Vol. 97 (2011May-Ju) , 259-64
Can magnetic resonance image-guided focused ultrasound surgery replace local oncology treatments? A review
Magnetic resonance image-guided focused ultrasound surgery (MRgFUS) is an innovative technology in the new panorama of treatment using ultrasound. It combines two well-known and distinct methodologies: high-intensity focused ultrasound (HIFU) and a magnetic resonance imaging system (MRI). This review on MRgFUS is focused on the technical aspects and the current clinical applications in oncology. More precisely, the advantages/disadvantages of MRgFUS compared to other local approaches such as surgery and radiotherapy are discussed in detail.
- 27 July 2011
- Vol. 97 (2011May-Ju) , 259-64
Can magnetic resonance image-guided focused ultrasound surgery replace local oncology treatments? A review
Magnetic resonance image-guided focused ultrasound surgery (MRgFUS) is an innovative technology in the new panorama of treatment using ultrasound. It combines two well-known and distinct methodologies: high-intensity focused ultrasound (HIFU) and a magnetic resonance imaging system (MRI). This review on MRgFUS is focused on the technical aspects and the current clinical applications in oncology. More precisely, the advantages/disadvantages of MRgFUS compared to other local approaches such as surgery and radiotherapy are discussed in detail.
- 31 May 2011
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 99, S245
597 poster DOSE DISTRIBUTION OPTIMIZATION WITH NOVAC7 USING THE PROTECTION DISC IN BREAST ELIOT: A MONTE CARLO – GEANT4 STUDY
- 31 May 2011
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 99, S245
597 poster DOSE DISTRIBUTION OPTIMIZATION WITH NOVAC7 USING THE PROTECTION DISC IN BREAST ELIOT: A MONTE CARLO – GEANT4 STUDY